DE vs DHR: Which Is the Better Buy?
Side-by-side comparison of Deere & Company and Danaher Corporation β fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Deere & Company Β· Industrials
$578.39
+22.4% upside to fair value
Grade C
VS
Danaher Corporation Β· Healthcare
$174.04
+13.2% upside to fair value
Grade B
QuantHub Verdict
DE has more upside to fair value
(+22.4%).
DE trades at a lower forward P/E
(32.5x).
These are model outputs β not personalized investment advice.
See all research β
Valuation & Fundamentals
| Metric |
DE |
DHR |
| Current Price |
$578.39 |
$174.04 |
| Fair Value Estimate |
$708.19 |
$197.01 |
| Upside to Fair Value |
+22.4%
|
+13.2%
|
| Market Cap |
$156.2B |
$123.2B |
| Forward P/E |
32.5x
|
33.4x
|
| EV / EBITDA |
18.4x
|
20.3x
|
| Price / Sales |
3.4x
|
5.0x
|
| Price / FCF |
43.7x
|
23.3x
|
| Revenue Growth YoY |
+16.3%
|
+3.7%
|
| Gross Margin |
35.6%
|
60.7%
|
| Operating Margin |
18.5%
|
21.0%
|
| Return on Equity |
18.9%
|
7.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
2.29%
|
4.3%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Deere & Company is a leading manufacturer of agricultural, construction, and forestry machinery, with a strong position in production and precision agriculture, small agriculture and turf, and construction and forestry segments. The company benefits from a durable competitive moat driven by its brand, intangible assets, and switching costs, supported by a CEO with deep institutional knowledge andβ¦
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record incβ¦
Accumulation Zones
| Metric |
DE |
DHR |
| Zone Low |
$531.14 |
$147.76 |
| Zone High |
$601.96 |
$167.46 |
| In Buy Zone? |
Yes
|
No
|